ATYR

aTyr Pharma
ATYR

Overview Fund Activity

56 hedge funds and large institutions have $81.5M invested in aTyr Pharma in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 5 closing their positions.

Holders
56
Holders Change
+10
Holders Change %
+21.74%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
20
Reduced
11
Closed
5
Calls
$15K
Puts
$8K
Net Calls
+$7K
Net Calls Change
+$5K

Top Buyers

1
WP
1
Woodline Partners
California
$3.28M
2
OCA
2
Octagon Capital Advisors
New York
$1.37M
3
GTC
3
Ghost Tree Capital
New York
$1.17M
4
Barclays
4
Barclays
United Kingdom
$1.18M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$2.48M

Top Sellers

1
LGM
1
Logos Global Management
California
$6.05M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$2.94M
3
SCM
3
Stonepine Capital Management
Oregon
$0
4
PFCS
4
Pale Fire Capital SE
Czech Republic
$178K
5
Squarepoint
5
Squarepoint
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
51
Qube Research & Technologies (QRT)
United Kingdom
$18.8K +$18.4K +9,456 +5,030%
TRCT
52
Tower Research Capital (TRC)
New York
$12.2K +$12.2K +6,267 New
Simplex Trading
53
Simplex Trading
Illinois
$11K +$11K +6,021 New
Wells Fargo
54
Wells Fargo
California
$3.73K +$14 +7 +0.4%
PP
55
PFS Partners
New Jersey
$663 – – –
CSC
56
Caldwell Sutter Capital
California
$101 – – –
SCM
57
Stonepine Capital Management
Oregon
– -$680K -482,258 Closed
Squarepoint
58
Squarepoint
New York
– -$168K -119,450 Closed
VF
59
Virtu Financial
New York
– -$37K -26,409 Closed
GBWM
60
Granite Bay Wealth Management
New Hampshire
– -$22K -18,000 Closed
Bank of New York Mellon
61
Bank of New York Mellon
New York
– -$23.2K -16,426 Closed
1 2
3